Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

Nature Medicine

Volumn 9, Issue 2, 2003, Pages 213-219

  Joseph, Sean B ^a   Castrillo, Antonio ^a   Laffitte, Bryan A ^a   Mangelsdorf, David J ^b   Tontonoz, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; GW 1516; GW 7647; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIGAND; LIPOPOLYSACCHARIDE; LIVER X RECEPTOR; LIVER X RECEPTOR STIMULATING AGENT; NITRIC OXIDE SYNTHASE; RECEPTOR; ROSIGLITAZONE; T 1317; TO 901317; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CONTACT DERMATITIS; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; IMMUNE SYSTEM; INFLAMMATION; LIPID METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; INFLAMMATION; LIPIDS; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0037324340     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm820     Document Type: Article

References (40)

1. Glass, C.K. & Witztum, J.L. Atherosclerosis. The road ahead. Cell 104, 503-516 (2001).
2. Lusis, A.J. Atherosclerosis. Nature 407, 233-241 (2000).
3. Febbraio, M. et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105, 1049-1056 (2000).
4. Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-295 (1997).
5. Detmers, P.A. et al. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol. 165, 3430-3435 (2000).
6. Gu, L. et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281 (1998).
7. Kuhlencordt, P.J., Chen, J., Han, F., Astern, J. & Huang, P.L. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103, 3099-3104 (2001).
8. Hansson, G.K. Inflammation and immune response in atherosclerosis. Curr. Atheroscler. Rep. 1, 150-155 (1999).
9. Wu, Z.L., Liang, M.Y. & Qiu, L.Q. Oxidized low-density lipoprotein decreases the induced nitric oxide synthesis in rat mesangial cells. Cell Biochem. Funct. 16, 153-158 (1998).
10. Liu, S.X., Chen, Y., Zhou, M. & Wan, J. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages. Atherosclerosis 136, 43-49 (1998).
11. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H. & Evans, R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229-240 (1998).
12. Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A. & Evans, R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252 (1998).
13. Jiang, C., Ting, A.T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86 (1998).
14. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82 (1998).
15. Chawla, A. et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Med. 7, 48-52 (2001).
16. Moore, K.J. et al. The role of PPAR-γ in macrophage differentiation and cholesterol uptake. Nature Med. 7, 41-47 (2001).
17. Repa, J.J. & Mangelsdorf, D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16, 459-481 (2000).
18. Fu, X. et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276, 38378-38387 (2001).
19. Laffitte, B.A. & Tontonoz, P. Orphan nuclear receptors find a home in the arterial wall. Curr. Atheroscler. Rep. 4, 213-221 (2002).
20. Repa, J.J. & Mangelsdorf, D.J. The liver X receptor gene team: Potential new players in atherosclerosis. Nature Med. 8, 1243-1248 (2002).
21. Joseph, S.B. et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99, 7604-7609 (2002).
22. Tangirala, R.K. et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA 99, 11896-11901 (2002).
23. Lowenstein, C.J. et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90, 9730-9734 (1993).
24. Mestre, J.R. et al. Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells. J. Biol. Chem. 276, 3977-3982 (2001).
25. Sheu, M.Y. et al. Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models. J. Invest. Dermatol. 118, 94-101 (2002).
26. Karin, M. & Chang, L. AP-1-glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169, 447-451 (2001).
27. Herrlich, P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20, 2465-2475 (2001).
28. Nissen, R.M. & Yamamoto, K.R. The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314-2329 (2000).
29. Straus, D.S. et al. 15-Deoxy-δ 12,14-prostaglandin J2 inhibits multiple steps in the NF-κ B signaling pathway. Proc. Natl. Acad. Sci. USA 97, 4844-4849 (2000).
30. Li, M., Pascual, G. & Glass, C.K. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20, 4699-4707 (2000).
31. Chawla, A. et al. A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7, 161-171 (2001).
32. Galis, Z.S. et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ. Res. 91, 852-859 (2002).
33. Galis, Z.S., Sukhova, G.K., Kranzhofer, R., Clark, S. & Libby, P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92, 402-406 (1995).
34. Pasterkamp, G. et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150, 245-253 (2000).
35. Castrillo, A. et al. Inhibition of the nuclear factor κ B (NF-κ B) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-κ B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J. Biol. Chem. 276, 15854-15860 (2001).
36. Laffitte, B.A. et al. Autoregulation of the human liver X receptor alpha promoter. Mol. Cell. Biol. 21, 7558-7568 (2001).
37. Callejas, N.A., Bosca, L., Williams, C.S., Du, B.R. & Martin-Sanz, P. Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins. Gastroenterology 119, 493-501 (2000).
38. Chen, L.M., Kaniga, K. & Galan, J.E. Salmonella spp. are cytotoxic for cultured macrophages. Mol. Microbiol. 21, 1101-1115 (1996).
39. Castrillo, A., Diaz-Guerra, M.J., Hortelano, S., Martin-Sanz, P. & Bosca, L. Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy- Delta(12,14)-prostaglandin J(2) in activated murine macrophages. Mol. Cell. Biol. 20, 1692-1698 (2000).
40. Joseph, S.B. et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277, 11019-11025 (2002).